Co-Diagnostics, Inc. Announces Recent Grant Awards
The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jul 23
The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis…
20 Jul 23
On 5 May 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11…
19 Jul 23
Emory Hernandez Valadez claims that heavy exposure to the company's talc starting in his early years led to…
19 Jul 23
The products involved in the deal include FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, ZERVIATE, and non-prescription brands FRESHKOTE and…
19 Jul 23
In a Phase 2 study, navacaprant (NMRA-140) monotherapy demonstrated statistically significant and clinically meaningful reductions in symptoms of…
19 Jul 23
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to biopharma customers. Launch…
18 Jul 23
In the trial, acoramidis showed statistically significant improvement in the primary endpoint by a Win Ratio of 1.8…
18 Jul 23
The US health regulator gave its approval after the Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted in favour…
18 Jul 23
In the trial, donanemab lowered the risk of disease progression and half of the participants who were at…
18 Jul 23
These recommendations, which have been developed through the Executive Steering Group on Shortages and Safety of Medicinal Products…